Showing posts with label Current Trends in Gastroenterology and Hepatology. Show all posts
Showing posts with label Current Trends in Gastroenterology and Hepatology. Show all posts

Tuesday, 29 August 2023

Lupine Publishers | Food Sources and Bioavailability of Calcium

 Lupine Publishers | Journal of Gastroenterology and Hepatology


Abstract

The identification of the calcium ration by self-questionnaires validated in the region of Blida and the Wilayas of approximately is one of the rare studies in Algeria. She was interested in a part of the Algerian population with characteristics that do not seem very different from the general population; however, this dietary survey must be supplemented by a study on a representative sample of the general population. The study showed insufficient calcium intake mainly secondary to low consumption of milk and dairy products. This low calcium intake was objectified by the two questioning methods (Fardellone and CERIN), however, it will be desirable to establish Algerian self-questionnaires validated and verified by our learned society. The results obtained are worrying, which obliges us to immediately introduce a prevention and control strategy against the multiple pathologies linked to this low calcium intake, the main one being osteoporosis with its serious fracture complications.

Keywords:Calcium; Milk ; Oxalic Acid; Self-Questionnaire ; Bioavailability

Introduction

The role of calcium in nutritional balance and its importance in the proper functioning of the

body are widely accepted [1]. Calcium is very common in the diet, however it is milk and its derivatives that exhibit optimal bioavailability [2]. The interest of studying the factors influencing this bioavailability is capital for better management of dietary advice to cover calcium needs; calcium absorption depending on the source of calcium and the nature of the diet [3,4]. Our study aims to define the dietary sources of calcium, the factors influencing the absorbability and its bioavailability in order to adapt the diets to calcium needs.

Patients and Methods

100 volunteers of both sexes aged between 20 and 60 years, from the regions of central Algeria (Médéa, Chlef and Ain Defla) participated in the cross-sectional study for 3 months in 2021.

Inclusion Criteria

a) Healthy subjects, without specific and active medical or surgical history.

Non-Inclusion Criteria

a) subjects with, in particular, a digestive pathology with repercussions on the absorption of calcium

b) subjects with an endocrine (goiter) or metabolic disorder (diabetes, obesity)

c) pregnant or breastfeeding women

d) subjects under calcium supplementation

The survey carried out is based on a validated frequency self-questionnaire (Fardellone) as a model for questioning the main dietary sources of calcium, the level of daily calcium intake and factors reducing its bioavailability. This frequency self-questionnaire comprises 20 items whose calcium content is assessed using Fardellone equivalence tables; each item is associated with a multiplying coefficient making it possible to obtain a result in mg / day.

Foods are divided into 6 groups

a) Dairy products group

b) Group of cereals, starches and pulses

c) Group of meats, fish and eggs

d) Confectionery group and particularly chocolate factories

e) Group of drinks (water, fruit juice, coffee and tea)

The descriptive analysis of the population is based on the calculation of means and standard deviations for quantitative variables and percentages for those which are qualitative. Data entry and statistical analysis are performed using SPSS4 statistical software.

Results

The study workforce was 60% women and 40% men. Subjects over 60 years of age represented 60% of the total population. The work revealed an insufficient calcium intake (calcium intake of 659, 12 mg / d in men and 736.62 mg / d) essentially linked to a low consumption of milk and dairy products and a high consumption of foods containing oxalic acid: beetroot, spinach, coffee and tea in 96% of the study population.

Discussion

The population who participated in the study is predominantly female (60%) and relatively young (71% of the subjects surveyed had an average age of 28.71 years). We have adopted the WHO references for daily consumption levels, i.e.: low intake level for consumption <500 mg / d, mediocre intake level for calcium inputs of 500-999 mg / d and a suitable level for an intake> 1000 mg / d [4]. Based on the Fardellone frequency self-questionnaire, easily performed, reliable and adapted to our eating habits, the low absorbability of calcium has been associated with the current consumption of products rich in oxalic acid (contained in beets, spinach, tea and coffee) which affects the digestive relay of calcium bioavailability [5]. Overall, our results are similar to those obtained in Morocco [6] where the average calcium intake is 699 mg / d in a population aged between 16 and 59 years, and, also to those found in Tunisia [7] in the survey which concerned premenopausal Tunisian women whose calcium intake was greater than 800 mg / day in only 4% of those concerned.

Conclusion

The results will be alarming, which encourages the immediate implementation of a prevention program for poor calcium status linked to the low calcium content of the food intake or its poor bioavailability in order to deal with the resulting pathological consequences such as osteoporosis exposing to major fracture risks. This survey must be reinforced by a study on a representative sample of the Algerian population.

Read More About Lupine Publishers Journal of Gastroenterology and Hepatology Please Clock on the Below Link: https://currenttrendsingastroenterology.blogspot.com/



Tuesday, 11 July 2023

Lupine Publishers | Different Toxicity of Aristolochic Acids in Kidney and Liver

 Lupine Publishers | Current Trends in Gastroenterology and Hepatology


Introduction

 Aristolochic acid (AAs) is a group of nitrophenanthrene compounds comprised of AAI, AAII, AAIII and AAIV, which are widely found in Aristolochia plants and used in herbal therapy and traditional Chinese medicine [1]. Consistent use of aristolochic acids- containing drugs could lead to aristolochic acid nephropathy and subsequent urinary tract tumors [2-4]. Active metabolites of AAs form adducts with DNA, inducing characteristic A-T transversion (A:T to T:A mutation) known as AA mutational signature [5]. In 2017, a study has analyzed AA mutational signature of several datasets and concluded that AAs and their derivatives were widely implicated in liver cancers in Taiwan and throughout Asia [6]. Ever since the paper published, there has been an intensive debate on whether the prevalence of AA signature mutation is high in HCC patients and if this mutation spectra is really correlate with traditional Chinese medicine consumption in Asia. Since no case report has linked AAI to liver cancer by far, many researchers held doubts regarding AA-induced liver cancer. Herein, we summarized previous reports of animal experiments indicating the organ specified toxicity in kidney other than liver and shared our opinion about the possible reasons.

For long, several reports have linked AAs to the development of urothelial cancer, kidney and forestomach tumors in rodents [7-11]. Although AA could be bioactivated in both kidney and liver, in most studies, it only induces tumors in kidney [12]. Therefore, kidney was usually considered as the prior target organ of AAs. AA-DNA adduct is a well-known biomarker for AA exposure. Studies conducted on rat kidney and liver found that kidney had at least two-fold higher levels of DNA adducts and mutant frequency than livers inducted by AAI [13, 14]. The same dose didn’t cause liver tumor in rat, but DNA adducts were detectable at lower levels than kidney [13]. The experiment on Muta mice showed the same tendency [15]. A most recent study also indicated that although forestomach carcinoma was the main cause of death in long-term small dose (0.3-3.0 mg/ kg) AAI-treated mice, kidney was still the organ with most AA-DNA adducts accumulation compared with forestomach and liver [16].

There are several possible reasons for the tissue specificity of AA, one of which could be the ability of proximal tubules to transport and concentrate AA and their metabolites, resulting in renal toxicity. OAT family, mainly expressed on renal proximal tubules, is considered to be one of the pivotal determinants mediating the accumulation of AAI into the proximal tubules [17]. In addition, the level of enzymes catalyzing the reductive activation of AAI are varied in different cells. The activation pathway for AAI is nitroreduction catalyzed by both cytosolic and microsomal enzymes. One of the main human and rat enzymes activating AA-I toxicity was NAD(P) H:quinone oxidoreductase (NQO1), present in hepatic and renal cytosolic subcellular fractions. Other involving enzymes include NADPH: CYP reductase (POR) in kidney microsomes and protaglandin H synthase (cyclooxygenase, COX) in urothelial tissues [18]. In addition to gene expression level of the AAI activation related enzymes in liver and kidney, in vivo oxygen concentration in specific tissues might also affect the balance between AAI nitroreduction and demethylation, which in turn would influence tissue-specific toxicity or carcinogenicity [19]. A recent study also indicated that hepatocyte-specific metabolism of AA-I substantially increases its cytotoxicity toward kidney proximal tubular epithelial cells, including formation of aristolactam adducts and release of kidney injury biomarkers [20].Moreover, AA exposure could cause significantly altered gene expression profiles between kidney and liver, involving defense response, apoptosis and immune response, cell cycle etc, which might also be possible reasons for the tissue-specific toxicity and carcinogenicity of AA [12, 21].

Although the toxicity and carcinogenesis of AAs in kidney is well-defined, their role in liver damage and tumor development may be different. Besides, AA exposure as the main cause of liver cancer was not consistent with the actual scenario in Asia since hepatitis B virus infection remains as the highest risk. Therefore, we believe the toxicity of AAs in liver and kidney should be considered separately.

Read more about Lupine Publishers Journal of Gastroenterology and Hepatology Click on the below link: https://currenttrendsingastroenterology.blogspot.com/